- 专利标题: Management of stimulation safety limits in a neurostimulation system
-
申请号: US13470326申请日: 2012-05-13
-
公开(公告)号: US09950172B2公开(公告)日: 2018-04-24
- 发明人: Michael A. Moffitt , Sridhar Kothandaraman , David K. L. Peterson
- 申请人: Michael A. Moffitt , Sridhar Kothandaraman , David K. L. Peterson
- 申请人地址: US CA Valencia
- 专利权人: Boston Scientific Neuromodulation Corporation
- 当前专利权人: Boston Scientific Neuromodulation Corporation
- 当前专利权人地址: US CA Valencia
- 代理机构: Lowe Graham Jones PLLC
- 代理商 Bruce E. Black
- 主分类号: A61N1/00
- IPC分类号: A61N1/00 ; A61N1/36 ; A61N1/372
摘要:
A neurostimulation system for management of stimulation safety limits. The system determines a tissue charge injection metric at each electrode, compares the metric to the hard stop charge limit, and prevents the neurostimulator from delivering stimulation energy to the tissue region in accordance based on the comparison. The hard stop limit may be user-programmable or may be automatically modified in response to detection of electrode characteristics. The system may quantitatively notify a user of a value of the injected charge injected into the tissue. The electrodes may be organized into different sets, in which case, the system may directly control tissue charge independently at each of the electrode sets. If current steering is provided, the system may displace the electrical stimulation energy along the tissue region in one direction, while preventing the charge injection value at each of the electrodes from meeting or exceeding the hard stop charge limit.
公开/授权文献
信息查询